allergen immunotherapy


Also found in: Wikipedia.

allergen immunotherapy

a process of administering allergenic extracts to patients who suffer from allergic rhinoconjunctivitis and allergic asthma to decrease the degree of hypersensitivity and symptoms by reducing immunologic responses to environmental allergens like pollen, dust, animal dander, and molds; also highly effective for preventing anaphylaxis in patinets allergic to bee venom.

allergen immunotherapy

Desensitization, hyposensitization, immunotherapy Allergy medicine A modality that attempts to ↓ IgE-mediated hypersensitivity to various substances, by administering ever-increasing amounts of an antigen–eg urushiol in poison ivy, sumac, and pollen, to evoke formation of blocking antibodies. See Elimination diet, Immune tolerance; Cf Bee venom therapy.

al·ler·gen im·mu·no·ther·a·py

(alĕr-jen imyū-nō-thāră-pē)
Process of administering allergenic extracts to patients who suffer from allergic rhinoconjunctivitis and allergic asthma to decrease the degree of hypersensitivity and symptoms by reducing immunologic responses to environmental allergens like pollen, dust, animal dander, and molds.
References in periodicals archive ?
Headquartered in Holzkirchen, in Germany's Greater Munich area, the company will launch the SYMJEPI 0.3mg Injection for the emergency treatment of allergic reactions (Type 1) including anaphylaxis to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
Manufacture of commercial batches has been completed and Adamis will begin shipping to Sandoz distribution centers during December to ensure the appropriate supply for launch.SYMJEPI 0.3mg Injection is indicated for the emergency treatment of allergic reactions, including anaphylaxis, to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
under an exclusive agreement with Adamis Pharmaceuticals Corp."Today's approval of Symjepi in the pediatric setting is a huge step forward to treat children at increased risk for anaphylaxis as it represents an affordable alternative to current treatment offerings at a time when patients need access to this medicine most." Carol Lynch, president, Sandoz Inc.Symjepi 0.15 mg Injection is indicated for the emergency treatment of allergic reactions (Type 1) including anaphylaxis to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy. Allergy.
Specific allergen immunotherapy (SIT) is a unique therapy with an ability to change the natural evolution of allergic diseases.28 In this treatment modality, allergens are given to patients in repeated and gradually increasing doses to provide immune tolerance.
In some cases, allergen immunotherapy is an option.
"The majority of caregivers of children with food allergy were willing to consider enrolling their child in a clinical trial for allergen immunotherapy," the authors write.
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper.